Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; Postulation of unique roles of D3 receptors and BDNF in place preference acquisition

British Journal of Pharmacology

Volumn 172, Issue 20, 2015, Pages 4970-4984

  Ciudad Roberts, Andrés ^a   Camarasa, Jorge ^a   Ciudad, Carlos J ^a   Pubill, David ^a   Escubedo, Elena ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE; ALCOHOL; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 3 RECEPTOR; HALOPERIDOL; KETANSERIN; MESSENGER RNA; N [2 [[(HEXAHYDRO 2 OXO 1H AZEPIN 3 YL)AMINO]CARBONYL]PHENYL] BENZO[B]THIOPHENE 2 CARBOXAMIDE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CIRCADIAN RHYTHM; CONDITIONING; CONTROLLED STUDY; GENE EXPRESSION; GENE ONTOLOGY; GLIOSIS; LOCOMOTION; MALE; MEDIAL PREFRONTAL CORTEX; MITOSIS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OXIDATIVE STRESS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DNA MICROARRAY; DRUG EFFECTS; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENETICS; INSTRUMENTAL CONDITIONING; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DRUG SYNERGISM; ETHANOL; GENE EXPRESSION PROFILING; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, DOPAMINE D3;

EID: 84945265019     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13266     Document Type: Article

References (67)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., (2013b). The Concise Guide to PHARMACOLOGY 2013b. catalytic receptors. Br J Pharmacol 170: 1676-1705.
3. Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, et al., (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192-1203.
4. Beauvais G, Atwell K, Jayanthi S, Ladenheim B, Cadet JL, (2011). Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS One 6 e28946.
5. Ben Hamida S, Plute E, Bach S, Lazarus C, Tracqui A, Kelche C, et al., (2007). Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination. Psychopharmacology (Berl) 192: 555-569.
6. Ben Hamida S, Tracqui A, de Vasconcelos AP, Szwarc E, Lazarus C, Kelche C, et al., (2009). Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA. Int J Neuropsychopharmacol 12: 749-759.
7. Brunt TM, Poortman A, Niesink RJM, van den Brink W, (2011). Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 25: 1543-1547.
8. Casey BJ, Jones RM, Hare TA, (2008). The adolescent brain. Ann NY Acad Sci 1124: 111-126.
9. Cassel J-C, Jeltsch H, Koenig J, Jones BC, (2004). Locomotor and pyretic effects of MDMA-ethanol associations in rats. Alcohol 34: 285-289.
10. Cazorla M, Premont J, Mann A, Girard N, Kellendonk C, Rognan D, (2011). Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 121: 1846-1857.
11. Chambers RA, Potenza MN, (2003). Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 19: 53-84.
12. Cingolani LA, Goda Y, (2008). Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 9: 344-356.
13. Ciudad-Roberts A, Camarasa J, Pubill D, Escubedo E, (2013). Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice. Prog Neuropsychopharmacol Biol Psychiatry 44: 201-209.
14. Collo G, Cavalleri L, Spano P, (2014). Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine. Front Pharmacol 5: 259.
15. Diaz J, Lévesque D, Griffon N, Lammers CH, Martres MP, Sokoloff P, et al., (1994). Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6: 1384-1387.
16. Elliot S, Evans J, (2014). A 3-year review of new psychoactive substances in casework. Forensic Sci Int 243: 55-60.
17. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report (2010). ISBN/ISSN: 978-92-9168-432-8. Available at: www.emcdda.europa.eu/publications/annual-report/2010 (accessed 9/3/2015).
18. Everitt BJ, Wolf ME, (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312-3320.
19. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW, (2007). Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10: 1029-1037.
20. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI, (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55: 463-508.
21. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P, (2001). BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411: 86-89.
22. Higley AE, Kiefer SW, Li X, Gaál J, Xi Z-X, Gardner EL, (2011). Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats. Eur J Pharmacol 659: 187-192.
23. Hodge CW, Kelley SP, Bratt AM, Iller K, Schroeder JP, Besheer J, (2004). 5-HT(3A) receptor subunit is required for 5-HT3 antagonist-induced reductions in alcohol drinking. Neuropsychopharmacology 29: 1807-1813.
24. Izawa J, Yamanashi K, Asakura T, Misu Y, Goshima Y, (2006). Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. Eur J Pharmacol 549: 84-90.
25. Izenwasser S, (2005). Differential effects of psychoactive drugs in adolescents and adults. Crit Rev Neurobiol 17: 51-67.
26. Jones BC, Ben-Hamida S, de Vasconcelos AP, Kelche C, Lazarus C, Jackisch R, et al., (2010). Effects of ethanol and ecstasy on conditioned place preference in the rat. J Psychopharmacol 24: 275-279.
27. Karlsson L, Andersson M, Kronstrand R, Kugelberg FC, (2014). Mephedrone, Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice. Basic Clin Pharmacol Toxicol. doi: 10.1111/bcpt.12253.
28. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, et al., (2011). Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164: 1949-1958.
29. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, et al., (1998). Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18: 3470-3479.
30. Le Foll B, Diaz J, Sokoloff P, (2005). A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 16: 175-178.
31. Leggio GM, Camillieri G, Platania C, Castorina A, Marrazzo G, Torrisi S, et al., (2014). Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone. Neuropsychopharmacology. doi: 10.1038/npp.2014.51.
32. Levant B, (1997). The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49: 231-252.
33. Liang J, Zheng X, Chen J, Li Y, Xing X, Bai Y, et al., (2011). Roles of BDNF, dopamine D(3) receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization. Eur Neuropsychopharmacol 21: 825-834.
34. Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, et al., (2012). Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126: 257-262.
35. Liu XY, Mao LM, Zhang GC, Papasian CJ, Fibuch EE, Lan HX, et al., (2009). Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 61: 425-438.
36. Livak KJ, Schmittgen TD, (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
37. Lõpez-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J, (2012). Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167: 407-420.
38. Martínez-Clemente J, Escubedo E, Pubill D, Camarasa J, (2012). Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 22: 231-236.
39. Martinez-Clemente J, Lopez-Arnau R, Abad S, Pubill D, Escubedo E, Camarasa J, (2014). Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One 9 e99002.
40. Mash DC, Staley JK, (1999). D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims. Ann N Y Acad Sci 877: 507-522.
41. Maurice T, Casalino M, Lacroix M, Romieu P, (2003). Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice. Pharmacol Biochem Behav 74: 869-876.
42. Measham F, Moore K, Newcombe R, Welch Z, (2010). Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. DrugsAlcohol Today 10: 14-21.
43. Mitchell JM, O'Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL, (2012). Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med 4 116ra6.
44. Mulligan MK, Rhodes JS, Crabbe JC, Mayfield RD, Harris RA, Ponomarev I, (2011). Molecular profiles of drinking alcohol to intoxication in C57BL/6 J mice. Alcohol Clin Exp Res 35: 659-670.
45. Mühlenhoff U, Richhardt N, Gerber J, Lill R, (2002). Characterization of iron-sulfur protein assembly in isolated mitochondria. A requirement for ATP, NADH, and reduced iron. J Biol Chem 277: 29810-29816.
46. Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA, (1994). Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci Lett 177: 111-115.
47. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P, (2012). Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol 84: 882-890.
48. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-106.
49. Piechota M, Korostynski M, Sikora M, Golda S, Dzbek J, Przewlocki R, (2012). Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine. Genes Brain Behav 11: 404-414.
50. Reagan-Shaw S, Nihal M, Ahmad N, (2008). Dose translation from animal to human studies revisited. FASEB J 22: 659-661.
51. Riegert C, Wedekind F, Ben Hamida S, Rutz S, Rothmaier AK, Jones BC, et al., (2008). Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain. Int J Neuropsychopharmacol 11: 743-763.
52. Ryder PV, Vistein R, Gokhale A, Seaman MN, Puthenveedu MA, Faundez V, (2013). The WASH complex, an endosomal Arp2/3 activator, interacts with the Hermansky-Pudlak syndrome complex BLOC-1 and its cargo phosphatidylinositol-4-kinase type IIα. Mol Biol Cell 24: 2269-2284.
53. Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, et al., (2011). Mephedrone (4-methylmethcathinone; "meow meow"): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214: 593-602.
54. Scolnick JA, Cui K, Duggan CD, Xuan S, Yuan X-B, Efstratiadis A, et al., (2008). Role of IGF signaling in olfactory sensory map formation and axon guidance. Neuron 57: 847-857.
55. Siggins GR, Roberto M, Nie Z, (2005). The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther 107: 80-98.
56. Song R, Yang R-F, Wu N, Su R-B, Li J, Peng X-Q, et al., (2012). YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict Biol 17: 259-273.
57. Spangler R, Goddard NL, Avena NM, Hoebel BG, Leibowitz SF, (2003). Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res Mol Brain Res 111: 74-83.
58. Spear LP, (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
59. Squeglia LM, Jacobus J, Tapert SF, (2009). The influence of substance use on adolescent brain development. Clin EEG Neurosci 40: 31-38.
60. Steinberg L, (2005). Cognitive and affective development in adolescence. Trends Cogn Sci 9: 69-74.
61. Stradal TEB, Scita G, (2006). Protein complexes regulating Arp2/3-mediated actin assembly. Curr Opin Cell Biol 18: 4-10.
62. Tzschentke TM, (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227-462.
63. Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G, et al., (2006). The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20: 2223-2233.
64. Vorel SR, Ashby CR, Paul M, Liu X, Hayes R, Hagan JJ, et al., (2002). Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22: 9595-9603.
65. Williams AA, Ingram WM, Levine S, Resnik J, Kamel CM, Lish JR, et al., (2012). Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology 37: 2285-2298.
66. Winstock AR, Mitcheson LR, Ramsey J, Davies S, Puchnarewicz M, Marsden J, (2011). Mephedrone: use, subjective effects and health risks. Addiction 106: 1991-1996.
67. Yuferov V, Nielsen D, Butelman E, Kreek MJ, (2005). Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol 10: 101-118.